Rivers d k (27 Ergebnisse)

Paperback or Softback. Zustand: New. Remnavax: The Discovery. Book.

Zustand: New.

Hardcover. Zustand: Very good. Green octavo (green and dark blue spine); errata slip taped to front pastedown, xxii, 484 p; 24 cm. Medicine; Philosophy. Bumped corners, faint fade-marks to boards, small ownership signature to front free endpaper, bright pages; binding is tight. Very good+. First edition (presumed; no earlier dates stated).…

hardcover. Zustand: Very Good. 1st Edition. Used - Very Good.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New.

Hardcover. Zustand: Very Good. 1st Edition. Very good, clean, tight condition. Text free of marks. Professional book dealer since 1999. All orders are processed promptly and carefully packaged.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: Good. 1st Edition. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.…

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Paperback. Zustand: Brand New. 374 pages. 5.00x0.94x8.00 inches. In Stock.

Hardcover. Zustand: Brand New. 379 pages. 6.24x1.14x9.24 inches. In Stock.

Paperback. Zustand: new. Paperback. In the midst of the COVID-19 pandemic, Dr. Sofia Mendes, a brilliant and dedicated physician, finds herself at the center of a race against time to develop a groundbreaking vaccine. Working tirelessly alongside her colleague, Dr. Jolie Harding, at the Racquers Virology Center in London, Sofia revives an abandoned research project known as Vitalis Redux, a theoretical treatment designed to disrupt viral replication using decoy molecules rather than direct viral targeting. As the crisis at St. Margaret's Hospital escalates, with resources dwindling and mortality rates soaring, Sofia and Jolie secure funding from the notorious financier Magnus Vale to accelerate their work. Despite deep ethical reservations about Vale's reputation for exploiting medical breakthroughs, they recognize the urgency of the moment and the potential of their research to save countless lives. Under intense pressure from both the pandemic and Vale's demands, Sofia and Jolie make a remarkable discovery. Their vaccine candidate, REMNAVAX, does not merely train the immune system to recognize a single virus. Instead, it appears capable of anticipating future mutations, adapting dynamically as viral structures change. As the data accumulates, the results become increasingly unsettling. The immune response is not just effective. It is flawless. Too consistent. Too complete. Patterns emerge that suggest the system is learning in ways no model predicted, hinting at a form of biological optimization that borders on permanence. While the scientific implications are staggering, their triumph is quickly overshadowed by the realities of power, bureaucracy, and narrative control. Sofia and Jolie face mounting scrutiny, surveillance, competitor backlash, and subtle attempts to steer the public story of REMNAVAX toward commercial and political ends. As the vaccine undergoes rigorous testing and validation, the moral cost of their partnership with Vale becomes harder to ignore, particularly as he moves to position the breakthrough as a proprietary asset rather than a shared human safeguard. At the same time, Sofia struggles to maintain any balance between her consuming work and her family life. Her husband, Carlos, and her twin daughters, Kamila and Amelia, bear the emotional weight of her absence, even as the world looks to her as a quiet architect of salvation.The story culminates in the successful global rollout of REMNAVAX, which helps bring the pandemic to an end. Yet the aftermath proves stranger than victory itself. Public attention shifts. Gratitude fades. The scientists behind the cure find themselves displaced, their achievement absorbed into systems that no longer see them. Sofia and Jolie are left to confront the paradox of absolute success: when a solution works perfectly, it disappears from view. In the closing movement of the novel, Sofia returns to her family, determined to reclaim a life beyond crisis. But the data does not let go so easily. A subtle, long-term effect begins to surface, one that suggests REMNAVAX has altered more than viral immunity. The implications point toward new frontiers in cellular biology and a future shaped by consequences no one has yet named. Remnavax explores scientific ethics, the tension between public good and private power, personal identity under institutional pressure, and the cost of solving the world's problems too well. Blending medical fiction, political thriller, and emotional drama, the novel lays the foundation for a trilogy that examines what happens after humanity wins, and what that victory quietly sets in motion.Publisher: BookFuel Remnavax: The Discovery follows Dr. Sofia Mendes, a virologist turned ER doctor battling a collapsing system during COVID-19. When a buried project resurfaces, she and Jolie Harding cr Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Buch. Zustand: Neu. Neuware - A pandemic. A breakthrough. A discovery that may change humanity forever.In this thought-provoking COVID-19 era medical thriller, a brilliant and dedicated physician finds herself at the center of a race against time to develop a groundbreaking vaccine.In the midst of the COVID-19 pandemic, Dr. Sofia Mendes, working on the front lines in London, joins forces with immunologist Dr. Jolie Harding at the Racquers Virology Center to revive an abandoned research project known as Vitalis Redux. Instead of targeting the virus directly, the experimental approach uses molecular decoys designed to disrupt viral replication itself.As hospitals begin to collapse under the pressure of the pandemic, the team secures funding from controversial financier Magnus Vale, whose interest in the project raises troubling ethical questions. With time running out, Sofia and Jolie push forward, hoping their breakthrough will save millions.What they discover soon challenges everything they thought possible.Their vaccine candidate, REMNAVAX, does more than teach the immune system to recognize a virus. It appears capable of anticipating future mutations, dynamically adapting as viral structures evolve.At first the results look miraculous.Then they become unsettling.The immune response is not merely effective. It is flawless. Too consistent. Too complete. Patterns begin to emerge suggesting the system is learning in ways no biological model predicted.As REMNAVAX moves toward global deployment, scientific triumph collides with political pressure, corporate ambition, and the struggle to control the narrative of the greatest medical breakthrough in history.But when subtle long-term signals begin appearing in the data, Sofia realizes their discovery may have changed far more than viral immunity.Remnavax is a gripping medical thriller exploring science, power, and the hidden consequences of innovation.Perfect for readers who enjoy the high-stakes scientific suspense of Michael Crichton and Robin Cook, Remnavax blends medical realism, speculative science, and political intrigue in a story about what happens when humanity solves the wrong problem perfectly.…

Zustand: New. Print on Demand.

Zustand: New. Print on Demand.

Zustand: New. Print on Demand.

Zustand: New. PRINT ON DEMAND.

Zustand: New. Print on Demand.

Zustand: New. PRINT ON DEMAND.

Paperback / softback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Paperback / softback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In the midst of the COVID-19 pandemic, Dr. Sofia Mendes, a brilliant and dedicated physician, finds herself at the center of a race against time to develop a groundbreaking vaccine. Working tirelessly alongside her colleague, Dr. Jolie Harding, at the Racquers Virology Center in London, Sofia revives an abandoned research project known as Vitalis Redux, a theoretical treatment designed to disrupt viral replication using decoy molecules rather than direct viral targeting. As the crisis at St. Margaret's Hospital escalates, with resources dwindling and mortality rates soaring, Sofia and Jolie secure funding from the notorious financier Magnus Vale to accelerate their work. Despite deep ethical reservations about Vale's reputation for exploiting medical breakthroughs, they recognize the urgency of the moment and the potential of their research to save countless lives. Under intense pressure from both the pandemic and Vale's demands, Sofia and Jolie make a remarkable discovery. Their vaccine candidate, REMNAVAX, does not merely train the immune system to recognize a single virus. Instead, it appears capable of anticipating future mutations, adapting dynamically as viral structures change. As the data accumulates, the results become increasingly unsettling. The immune response is not just effective. It is flawless. Too consistent. Too complete. Patterns emerge that suggest the system is learning in ways no model predicted, hinting at a form of biological optimization that borders on permanence. While the scientific implications are staggering, their triumph is quickly overshadowed by the realities of power, bureaucracy, and narrative control. Sofia and Jolie face mounting scrutiny, surveillance, competitor backlash, and subtle attempts to steer the public story of REMNAVAX toward commercial and political ends. As the vaccine undergoes rigorous testing and validation, the moral cost of their partnership with Vale becomes harder to ignore, particularly as he moves to position the breakthrough as a proprietary asset rather than a shared human safeguard. At the same time, Sofia struggles to maintain any balance between her consuming work and her family life. Her husband, Carlos, and her twin daughters, Kamila and Amelia, bear the emotional weight of her absence, even as the world looks to her as a quiet architect of salvation.The story culminates in the successful global rollout of REMNAVAX, which helps bring the pandemic to an end. Yet the aftermath proves stranger than victory itself. Public attention shifts. Gratitude fades. The scientists behind the cure find themselves displaced, their achievement absorbed into systems that no longer see them. Sofia and Jolie are left to confront the paradox of absolute success: when a solution works perfectly, it disappears from view. In the closing movement of the novel, Sofia returns to her family, determined to reclaim a life beyond crisis. But the data does not let go so easily. A subtle, long-term effect begins to surface, one that suggests REMNAVAX has altered more than viral immunity. The implications point toward new frontiers in cellular biology and a future shaped by consequences no one has yet named. Remnavax explores scientific ethics, the tension between public good and private power, personal identity under institutional pressure, and the cost of solving the world's problems too well. Blending medical fiction, political thriller, and emotional drama, the novel lays the foundation for a trilogy that examines what happens after humanity wins, and what that victory quietly sets in motion.Publisher: BookFuel.…

Paperback. Zustand: new. Paperback. A pandemic. A breakthrough. A discovery that may change humanity forever.In this thought-provoking COVID-19 era medical thriller, a brilliant and dedicated physician finds herself at the center of a race against time to develop a groundbreaking vaccine.In the midst of the COVID-19 pandemic, Dr. Sofia Mendes, working on the front lines in London, joins forces with immunologist Dr. Jolie Harding at the Racquers Virology Center to revive an abandoned research project known as Vitalis Redux. Instead of targeting the virus directly, the experimental approach uses molecular decoys designed to disrupt viral replication itself.As hospitals begin to collapse under the pressure of the pandemic, the team secures funding from controversial financier Magnus Vale, whose interest in the project raises troubling ethical questions. With time running out, Sofia and Jolie push forward, hoping their breakthrough will save millions.What they discover soon challenges everything they thought possible.Their vaccine candidate, REMNAVAX, does more than teach the immune system to recognize a virus. It appears capable of anticipating future mutations, dynamically adapting as viral structures evolve.At first the results look miraculous.Then they become unsettling.The immune response is not merely effective. It is flawless. Too consistent. Too complete. Patterns begin to emerge suggesting the system is learning in ways no biological model predicted.As REMNAVAX moves toward global deployment, scientific triumph collides with political pressure, corporate ambition, and the struggle to control the narrative of the greatest medical breakthrough in history.But when subtle long-term signals begin appearing in the data, Sofia realizes their discovery may have changed far more than viral immunity.Remnavax is a gripping medical thriller exploring science, power, and the hidden consequences of innovation.Perfect for readers who enjoy the high-stakes scientific suspense of Michael Crichton and Robin Cook, Remnavax blends medical realism, speculative science, and political intrigue in a story about what happens when humanity solves the wrong problem perfectly. Remnavax: The Discovery follows Dr. Sofia Mendes, a virologist turned ER doctor battling a collapsing system during COVID-19. When a buried project resurfaces, she and Jolie Harding create an adaptive vaccine that can evolve. Backed by billionaire Magnus Vale, the science advances fast, at a dangerous cost. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Taschenbuch. Zustand: Neu. Remnavax | The Discovery | D. K. Rivers | Taschenbuch | Englisch | 2025 | Bookfuel | EAN 9781068296376 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.

Zustand: new. Questo è un articolo print on demand.